Online Only Articles

The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates

The IMED Respiratory, Inflammation & Autoimmunity Unit, AstraZeneca Gothenburg, Mölndal, Sweden
Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, U.K.
Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, U.K.
The IMED Respiratory, Inflammation & Autoimmunity Unit, AstraZeneca Gothenburg, Mölndal, Sweden
Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, U.K.
Vol. 102 No. 2 (2017): February, 2017 https://doi.org/10.3324/haematol.2016.152371